AMZN
Amazon.com, Inc.
AMZN has the edge over HMC overall, supported by stronger modeled upside and stronger fundamentals.
HMC
Honda Motor Co., Ltd.
HMC's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
HMC's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
HMC PE Valuation
HMC has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect HMC to return to profit, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HMC on earnings quality, reporting a profit while its opponent remains loss making.
HMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.81 | -131% |
| Q1 2026 | -$2.11 | -164% |
| Q4 2025 | $2.25 | -45% |
| Q3 2025 | $2.75 | -28% |
| Q2 2025 | $2.63 | -40% |
| Q1 2025 | $3.29 | -22% |
| Q4 2024 | $4.08 | +14% |
| Q3 2024 | $3.83 | +9.4% |
HMC has swung to a loss: it lost $0.81 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over HMC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HMC on profitability, with a higher operating margin.
HMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $38B | +14% |
| Q1 2026 | $36.5B | +8.6% |
| Q4 2025 | $33.5B | -3.4% |
| Q3 2025 | $33.2B | -1.9% |
| Q2 2025 | $33.5B | -1.2% |
| Q1 2025 | $33.6B | -1.3% |
| Q4 2024 | $34.7B | +2.6% |
| Q3 2024 | $33.8B | +8.2% |
HMC's revenue is growing: $38B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.8% | +4.2 points |
| Q1 2026 | -17% | -19 points |
| Q4 2025 | 2.9% | -4.3 points |
| Q3 2025 | 3.7% | -15 points |
| Q2 2025 | 4.6% | -4.4 points |
| Q1 2025 | 1.4% | -4.3 points |
| Q4 2024 | 7.2% | +0.1 points |
| Q3 2024 | 19% | +13 points |
HMC's operating margin was 8.8% last quarter, up 4.2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2B | -$1.4B |
| Q1 2026 | $870.1M | +$1.8B |
| Q4 2025 | $612.2M | +$1.3B |
| Q3 2025 | $726.9M | +$772.3M |
| Q2 2025 | -$719.2M | $0 |
| Q1 2025 | -$942.2M | $0 |
| Q4 2024 | -$683.5M | $0 |
| Q3 2024 | -$45.5M | $0 |
HMC has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +62.8M shares |
| 1 year | 0% | -42.7K shares |
| 3 years | -15% | -257M shares |
| 5 years | -19% | -326M shares |
| Available history | -20% | -359M shares |
HMC has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $576,658 |
| Q4 2025 | — |
| Q3 2025 | $1.9B |
| Q2 2025 | $2.3B |
| Q1 2025 | $2.7B |
| Q4 2024 | $423.3M |
| Q3 2024 | $1.3B |
HMC spent $1.9B buying back its own shares over the past year, down 71% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.8x | Moderate |
| Q3 2024 | 2.5x | Moderate |
HMC has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.9 | Neutral |
HMC's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HMC PE vs Consumer Cyclical Sector
| Metric | HMC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HMC has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over HMC on trend strength, trading above more of its moving averages.
HMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.6 | 0.2% below |
| 20 week MA | $31.9 | 5.3% above |
| 50 week MA | $29.4 | 14% above |
| 100 week MA | $29.7 | 13% above |
| 200 week MA | $30.3 | 11% above |
HMC has slipped below its 8-week average, but it's still above the other four, and 11% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over HMC on returns for 2026, with the stronger performance.
HMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $28.6 | -0.1% |
| 2021 | $28.6 | $28.1 | -1.7% |
| 2022 | $28.1 | $23.1 | -18% |
| 2023 | $23.1 | $30.9 | +34% |
| 2024 | $30.9 | $28.8 | -7% |
| 2025 | $28.8 | $29.8 | +3.6% |
| 2026 YTD | $29.8 | $33.5 | +13% |
HMC has finished lower in four of the last six years. It's up 13% so far in 2026.